Showing results (691-700 of 5,837) with videos related to

Sort By:
Pageof 584
Drug Design, Development and Therapy|June 18, 2021
The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's DiseaseGiovanni Abbruzzese, Paolo Barone, Leonardo Lopiano, et al.
Drug Design, Development and Therapy|June 9, 2021
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in MiceHuashan Li, Jianying Sheng, Jing Wang, et al.
Drug Design, Development and Therapy|June 9, 2021
Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male SubjectsSejung Hwang, Dae Young Lee, Joo-Youn Cho, et al.
Drug Design, Development and Therapy|March 19, 2020
Erratum: A Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of LiuWei DiHuang Pill in Treating Type 2 Diabetes Mellitus [Corrigendum]Dan He, Jian-Hua Huang, Zhe-Yu Zhang, et al.
Drug Design, Development and Therapy|March 19, 2020
Perindopril in Breast Milk and Determination of Breastfed Infant Exposure: A Prospective Observational StudyCatherine Leggett, Ei Mon Phyo Lwin, Usha Ritchie, et al.
Drug Design, Development and Therapy|March 19, 2020
Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated DeubiquitinationChengjiang Qiu, Kairui Liu, Sheng Zhang, et al.
Drug Design, Development and Therapy|March 19, 2020
Characterization and Evaluation of Antioxidant Activity of Aloe schelpei ReynoldsTekleab Teka, Haile Kassahun
Drug Design, Development and Therapy|March 12, 2020
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective StudyXinran Ma, Ling Li, Lei Zhang, et al.
Drug Design, Development and Therapy|March 12, 2020
Ox-LDL Causes Endothelial Cell Injury Through ASK1/NLRP3-Mediated Inflammasome Activation via Endoplasmic Reticulum StressLiwei Hang, Yan Peng, Rui Xiang, et al.
Drug Design, Development and Therapy|March 12, 2020
NVP-BSK805, an Inhibitor of JAK2 Kinase, Significantly Enhances the Radiosensitivity of Esophageal Squamous Cell Carcinoma in vitro and in vivoYuhui Hua, Weijia Wang, Xiaoli Zheng, et al.
Pageof 584